Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07014358
Starting soon Phase 4

Clinical Trial to Evaluate Three Systems of Osteosynthesis for Fixation of Olecranon Osteotomies in Adults

NCT07014358 · tracked via the Priya Life Science Spain tracker
Phase
Phase 4
Started
2025-06
Last updated
2025-06-11

Condition(s) studied

Olecranon Fracture

Investigational drug(s) / intervention(s)

Fastening systems by placing two steel pinsFastening systems by a wire in an obenque configurationFastening systems by the placement of a bolted plate or the placement of a compression screw

Fastening systems by placing two steel pins: Fixation of the osteotomized bone with a stable fixation system, in this case, the placement of two steel pins.

Fastening systems by a wire in an obenque configuration: Fixation of the osteotomized bone with a stable fixation system, in this case, an obenque configuration

Fastening systems by the placement of a bolted plate or the placement of a compression screw: Fixation of the osteotomized bone with a stable fixation system, in this case, the placement of a bolted plate or the placement of a compression screw.

Study summary

Surgery of the elbow joint is often made difficult by the highly constrained nature of the elbow joint. This is why it is often necessary to perform an osteotomy of the olecranon, the proximal part of the ulna, which allows perfect exposure of the entire articular surface. After performing the osteotomy, access to the joint is obtained, the articular problem is solved as appropriate and, upon completion, the osteotomized bone is fixed with a stable fixation system that allows the osteotomy to heal without problems. It is a safe, reproducible procedure that is associated with low associated morbidity. The main problems associated with this procedure are the lack of consolidation of the osteotomy or the need for removal of the osteosynthesis material at a later stage.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who, after receiving information about the design, the purposes of the study, the possible risks that may arise from it and the fact that they may refuse to collaborate at any time, give their written consent to participate in the study. * Be over 18 years of ag * Have an elbow disorder that is to be treated surgically through an olecranon osteotomy approach. * That the olecranon osteotomy is amenable to synthesization with the three proposed systems. * Understand the purpose of the study and be available for routine hospital visits. Exclusion Criteria: * Patients who have undergone ipsilateral elbow surgery. * Presence of ulnar fractures * Patients with an active infection at any site at the time of elbow surgery. * Inability to understand the procedure or information related to the study.

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Hospital Mutua Montañesa Santander Santander Cantabria
Clínica CEMTRO Madrid Madrid
Hospital de Manises Valencia Manises
Hospital La Fe Valencia Valencia
Hospital Universitario de Móstoles Madrid Spain

More Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07014358 on ClinicalTrials.gov ↗ ← All trials in Spain